How Can the European Federation for Colposcopy Promote High Quality Colposcopy Throughout Europe?

Since its inception in 1998, the European Federation for Colposcopy (EFC) now comprises 26 member societies. Its principle aim is to promote high quality colposcopy throughout Europe with special emphasis on training, education and treatment. This review summarises EFC’s activities and achievements to date

Additional file 1: of A novel RASA1 mutation causing capillary malformation-arteriovenous malformation (CM-AVM): the first genetic clinical report in East Asia

Cutaneous findings of the proband’s family. (DOC 37 kb

Additional file 2: of A novel RASA1 mutation causing capillary malformation-arteriovenous malformation (CM-AVM): the first genetic clinical report in East Asia

Information about the primers used to detect the c.3070A > T (p.Lys1024*) variant. (DOC 35 kb

MOESM2 of Identification and profiling of microRNAs responsive to cadmium toxicity in hepatopancreas of the freshwater crab Sinopotamon henanense

Additional file 2: Novel miRNA candidates identified from the hepatopancreas of the S. henanense

MOESM1 of Identification and profiling of microRNAs responsive to cadmium toxicity in hepatopancreas of the freshwater crab Sinopotamon henanense

Additional file 1: Conserved miRNAs identified from the hepatopancreas of the S. henanense

Supplementary File from Genome-wide DNA Methylation Analysis Reveals <i>GABBR2</i> as a Novel Epigenetic Target for <i>EGFR</i> 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment

Supplementary Methods and Figure legend of Supplementary Figure S1.</p

Table S2 from Genome-wide DNA Methylation Analysis Reveals <i>GABBR2</i> as a Novel Epigenetic Target for <i>EGFR</i> 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment

Sixty erlotinib-related aberrant DNA methylation genes in both patients discovered with the the methyl-sensitive cut counting sequencing (MSCC) screening method.</p

Table S1 from Genome-wide DNA Methylation Analysis Reveals <i>GABBR2</i> as a Novel Epigenetic Target for <i>EGFR</i> 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment

Data summary of methyl-sensitive cut counting sequencing (MSCC) sequencing of the 4 samples (8 libraries).</p

Figure S1 from Genome-wide DNA Methylation Analysis Reveals <i>GABBR2</i> as a Novel Epigenetic Target for <i>EGFR</i> 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment

The results proved that the whole-genome DNA methylation sequencing results were accurate and reliable from different aspects.</p

Table S3 from Genome-wide DNA Methylation Analysis Reveals <i>GABBR2</i> as a Novel Epigenetic Target for <i>EGFR</i> 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment

DNA methylation results of GABAA receptor families was relatively conservative before and after erlotinib treatment in both patients using methyl-sensitive cut counting sequencing (MSCC) screening method.</p